FindTrial
Sign In

Therapeutic utility of Kents Repertory in the treatment of chronic urticaria among the patients between the age group of 20 to 40 years.

A Single group, Pre-Post Study to assess the therapeutic utility of Kents Repertory in the treatment of Chronic urticaria among the Patients between the age group of 20 to 40 years - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073886
Enrollment
44
Registered
2024-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L501- Idiopathic urticaria

Interventions

Intervention1: Individualized Homoeopathic Medicine: All Patients enrolled in the study will be receiving homoeopathic medicine on the basis of individualization at frequency of one month of interval

Sponsors

Dr Anamika Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with clinical features of chronic spontaneous urticaria like wheals, nettle rash and itching. Patients between the age group between 20-40 years will be included. Patient who are willing to give consent for the study. Patient not under any homoeopathic treatment for last two weeks

Exclusion criteria

Exclusion criteria: Patients unwilling to participate in the study and unwilling to sign the informed consent. Patients with underlying malignancy or any such condition which needs emergency medical intervention. Patients who are undergoing homoeopathic treatment for any chronic disease for last 6 months.

Design outcomes

Primary

MeasureTime frame
The Disease severity will be measured with Urticaria Control Test-7(according to; author of scale, that scoring instructions of UCT7 are same as for UCT) where 0 the minimum and maximum UCT score [40] are 0 and 16 (developed by Marcus Maurer et al), with 16 points indicating complete disease control.Timepoint: Each patient will get follow-up for at least 3 months at the interval of 1 months—

Secondary

MeasureTime frame
secondary outcome will be measured using CU Q20l Health-related QoL of CU patients will be calculated by CU QoL Questionnaire.Timepoint: each patient will get follow up for at least 3 months at the interval of 1 month.—

Countries

India

Contacts

Public ContactDr Pradip Kumar Bairi

Mahesh Bhattacharyya Homeopathic Medical College and Hospital

drpkbairi@gmail.com943312293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026